Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current Evidence
Keyword(s):
Radiation therapy delivered with hypofractionation, which involves the delivery of a higher dose per fraction in fewer fractions (generally with a lower total nominal dose) over a shorter overall treatment time, is an established therapeutic option at least for a selected group of early breast cancer patients after breast-conserving surgery. Optimal delivery of the tumor bed boost dose in terms of timing, fractionation, and total dose whenever a hypofractionated schedule is employed has yet to be established. We herein present a review of the current evidence on the role of boost integration in whole breast radiotherapy.
2004 ◽
Vol 60
(4)
◽
pp. 1173-1181
◽
2017 ◽
Vol 35
(15_suppl)
◽
pp. e12090-e12090
◽
2002 ◽
Vol 54
(2)
◽
pp. 6-7
2009 ◽
Vol 27
(15_suppl)
◽
pp. 626-626
2020 ◽
Vol 18
(2)
◽